It appears that your browser has cookies disabled.
The website requires your browser to enable cookies in order to login.
Please enable cookies and reload this page.
Log In
Register for an account
Don't have a login? Register today to view list prices and apply for an account to purchase online!
Antigen Background
CD31(PECAM-1)は、130-140kDの単鎖膜貫通型糖タンパクです。CD31は血小板、単球、顆粒球、B細胞の細胞表面および血管内皮細胞に発現しています。この分子は、典型的な細胞間接着分子の特徴である、6つのC2サブクラスのIg-likehomology 部位を細胞外ドメインにもっています。この細胞外ドメインは、血管内皮細胞と細胞の接着に関与し、内皮細胞の単層構造を安定化させる働きをしている可能性があります。またCD31の細胞内ドメインには、細胞の活性化後のリン酸化を行う部位をもっています。CD31は、血管新生、血栓形成および創傷治癒の間の相互作用に関与することが示唆されています。血管新生は、腫瘍の成長や転移に大きな役割を果たしています。
Disclaimer
CD31 (PECAM-1) is recommended for the detection of specific antigens of interest in normal and neoplastic tissues, as an adjunct to conventional histopathology using non-immunologic histochemical stains.
Algeria
Andorra
Argentina
Armenia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia And Herzegowina
Brazil
Bulgaria
Canada
Chile
China
Cote D'Ivoire
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
French Guiana
Georgia
Germany
Ghana
Greece
Guadeloupe
Guyana
Holy See (Vatican City State)
Hong Kong
Hungary
Iceland
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kuwait
Latvia
Lebanon
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Malawi
Malta
Martinique
Mauritius
Mayotte
Mexico
Morocco
Netherlands
New Caledonia
New Zealand
Nigeria
Norway
Occupied Palestinian Territory
Oman
Pakistan
Paraguay
Philippines
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Saudi Arabia
Senegal
Serbia
Singapore
Slovakia (Slovak Republic)
Slovenia
South Africa
Spain
Sudan
Sweden
Switzerland
Taiwan
Tanzania, United Republic Of
Thailand
Togo
Trinidad And Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uzbekistan
Vietnam
Afghanistan
Algeria
Andorra
Argentina
Armenia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Benin
Bosnia And Herzegowina
Brazil
Bulgaria
Canada
Chile
China
Costa Rica
Cote D'Ivoire
Cyprus
Czech Republic
Denmark
Ecuador
Estonia
Ethiopia
Finland
France
French Guiana
Georgia
Germany
Greece
Guadeloupe
Guyana
Holy See (Vatican City State)
Hong Kong
Hungary
Iceland
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kuwait
Latvia
Lebanon
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Martinique
Mauritius
Mexico
Moldova, Republic Of
Morocco
Myanmar
Nepal
Netherlands
New Caledonia
New Zealand
Nigeria
Norway
Occupied Palestinian Territory
Oman
Pakistan
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Saudi Arabia
Senegal
Serbia
Singapore
Slovakia (Slovak Republic)
Slovenia
South Africa
Spain
Sudan
Sweden
Switzerland
Taiwan
Tanzania, United Republic Of
Thailand
Togo
Trinidad And Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uzbekistan
Vietnam
Afghanistan
Algeria
Angola
Argentina
Armenia
Australia
Austria
Bahrain
Belarus
Belgium
Bosnia And Herzegowina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Canada
Chile
China
Congo, The Democratic Republic Of The
Costa Rica
Cote D'Ivoire
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
France
French Guiana
Georgia
Germany
Greece
Guadeloupe
Holy See (Vatican City State)
Hong Kong
Hungary
Iceland
India
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kuwait
Latvia
Lebanon
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Malawi
Malta
Martinique
Mauritania
Mauritius
Mexico
Morocco
Myanmar
Namibia
Netherlands
New Caledonia
New Zealand
Nigeria
Norway
Occupied Palestinian Territory
Oman
Pakistan
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saudi Arabia
Singapore
Slovakia (Slovak Republic)
Slovenia
South Africa
South Korea
Spain
Sudan
Sweden
Switzerland
Taiwan
Tanzania, United Republic Of
Thailand
Trinidad And Tobago
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Vietnam
Zambia
Zimbabwe
Canada
Puerto Rico
Trinidad And Tobago
United States
Australia
Canada
New Zealand
Puerto Rico
Trinidad And Tobago
United States
Successfully added to cart
added to cart.
No item added to cart
The replacement product is no longer available, no item has been added to cart.
If you have any questions, contact us at 1.844.534.2262